Comment on "Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel: OLYMPUS trial final report"

Affiliations

¹ Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
² Department of Urology, Peking University People's Hospital, Beijing, 100044, China. xutao@pkuph.edu.cn.

Comment

Yuxuan Song et al. World J Urol. 2022 May.

. 2022 May;40(5):1251-1252.

doi: 10.1007/s00345-022-03968-7. Epub 2022 Feb 22.

¹ Department of Urology, Peking University People's Hospital, Beijing, 100044, China.
² Department of Urology, Peking University People's Hospital, Beijing, 100044, China. xutao@pkuph.edu.cn.

No abstract available

Comment on

Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final Report.
Matin SF, Pierorazio PM, Kleinmann N, Gore JL, Shabsigh A, Hu B, Chamie K, Godoy G, Hubosky SG, Rivera M, O'Donnell M, Quek M, Raman JD, Knoedler JJ, Scherr D, Weight C, Weizer A, Woods M, Kaimakliotis H, Smith AB, Linehan J, Coleman J, Humphreys MR, Pak R, Lifshitz D, Verni M, Klein I, Konorty M, Strauss-Ayali D, Hakim G, Seltzer E, Schoenberg M, Lerner SP. Matin SF, et al. J Urol. 2022 Apr;207(4):779-788. doi: 10.1097/JU.0000000000002350. Epub 2021 Dec 17. J Urol. 2022. PMID: 34915741 Free PMC article. Clinical Trial.

1. Matin SF, Pierorazio PM, Kleinmann N et al (2022) Durability of response to primary chemoablation of low-grade upper tract urothelial carcinoma using ugn-101 a mitomycin-containing reverse thermal gel: olympus trial final report. J Urol. https://doi.org/10.1097/JU.0000000000002350 - DOI - PubMed
1. Xylinas E, Colin P, Audenet F et al (2013) Intravesical recurrence after radical nephroureterectomy for upper tract urothelial carcinomas: predictors and impact on subsequent oncological outcomes from a national multicenter study. World J Urol 31:61–68. https://doi.org/10.1007/s00345-012-0957-3 - DOI - PubMed
1. Ko YH, Song PH, Park T, Choi JY (2020) Retrograde pyelography before radical nephroureterectomy for upper tract urothelial carcinoma is associated with intravesical tumor recurrence. Int Braz J Urol 46:778–785. https://doi.org/10.1590/s1677-5538.ibju.2019.0503 - DOI - PubMed - PMC
1. Baboudjian M, Al-Balushi K, Michel F et al (2020) Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage. World J Urol 38:159–165. https://doi.org/10.1007/s00345-019-02768-w - DOI - PubMed
1. Katims AB, Say R, Derweesh I et al (2021) Risk factors for intravesical recurrence after minimally invasive nephroureterectomy for upper tract urothelial cancer (robuust collaboration). J Urol 206:568–576. https://doi.org/10.1097/JU.0000000000001786 - DOI - PubMed